Skerlj Renato 4
4 · X4 Pharmaceuticals, Inc · Filed Aug 18, 2020
Insider Transaction Report
Form 4
Skerlj Renato
Chief Scientific Officer
Transactions
- Award
Common Stock
2020-08-17+8,750→ 47,910 total - Award
Common Stock
2020-08-14+8,750→ 39,160 total
Footnotes (4)
- [F1]Represents restricted stock units issued to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer and has no expiration date. One third of the shares underlying the restricted stock unit award vested on August 14, 2020. One third of the shares will vest on August 14, 2021, and one third of the shares will vest on August 14, 2022, subject to the Reporting Person providing continuous service to the Issuer on such dates. Shares in respect of the vested portion of the award must be delivered no later than March 15 of the calendar year following the year in which vesting occurs.
- [F2]Of the shares of common stock reported, 5,833 shares represent unvested restricted stock units.
- [F3]Represents restricted stock units issued to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer and has no expiration date. One third of the shares underlying the restricted stock unit award vested on August 17, 2020. One third of the shares will vest on August 17, 2021, and one third of the shares will vest on August 17, 2022, subject to the Reporting Person providing continuous service to the Issuer on such dates. Shares in respect of the vested portion of the award must be delivered no later than March 15 of the calendar year following the year in which vesting occurs.
- [F4]Of the shares of common stock reported, 11,666 shares represent unvested restricted stock units.